| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2020-02-14 | Redmile Group, LLC | ARRAY BIOPHARMA INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-08-12 | FMR LLC | ARRAY BIOPHARMA INC | 223,171 | 0.1% | EDGAR |
| SC 13G/A | 2019-07-10 | FMR LLC | ARRAY BIOPHARMA INC | 19,416,997 | 8.7% | EDGAR |
| SC 13G/A | 2019-02-14 | Redmile Group, LLC | ARRAY BIOPHARMA INC | 16,459,128 | 7.6% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | ARRAY BIOPHARMA INC | 31,693,502 | 14.9% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | ARRAY BIOPHARMA INC | 22,084,281 | 10.4% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | ARRAY BIOPHARMA INC | 16,962,200 | 8.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Point72 Asset Management, L.P. | ARRAY BIOPHARMA INC | 6,733,526 | 3.2% | EDGAR |
| SC 13G/A | 2018-02-14 | Redmile Group, LLC | ARRAY BIOPHARMA INC | 19,113,864 | 9.7% | EDGAR |
| SC 13G/A | 2018-02-13 | FMR LLC | ARRAY BIOPHARMA INC | 22,181,936 | 11.3% | EDGAR |
| SC 13G/A | 2018-02-13 | ORBIMED ADVISORS LLC | ARRAY BIOPHARMA INC | 3,322,200 | 1.7% | EDGAR |
| SC 13G/A | 2018-02-12 | VANGUARD GROUP INC | ARRAY BIOPHARMA INC | 21,719,581 | 11.0% | EDGAR |
| SC 13G/A | 2018-01-29 | BlackRock Inc. | ARRAY BIOPHARMA INC | 15,252,802 | 7.7% | EDGAR |
| SC 13G | 2017-09-12 | Point72 Asset Management, L.P. | ARRAY BIOPHARMA INC | 9,172,507 | 5.4% | EDGAR |
| SC 13G/A | 2017-04-10 | VANGUARD GROUP INC | ARRAY BIOPHARMA INC | 16,993,415 | 10.0% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | ARRAY BIOPHARMA INC | 24,800,136 | 14.7% | EDGAR |
| SC 13G/A | 2017-02-14 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 2,309,793 | 1.4% | EDGAR |
| SC 13G/A | 2017-02-14 | Flynn James E | ARRAY BIOPHARMA INC | 1,650,000 | 1.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Redmile Group, LLC | ARRAY BIOPHARMA INC | 16,618,776 | 9.9% | EDGAR |
| SC 13G/A | 2017-02-13 | ORBIMED ADVISORS LLC | ARRAY BIOPHARMA INC | 5,667,500 | 3.4% | EDGAR |